Clinical Trial Update: Aspirin Discontinuation in High-Risk Pregnant Women of Preeclampsia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating discontinuation of aspirin in high-risk pregnant women with preeclampsia, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Perinatal Hemorrhage
• Preeclampsia

Drugs mentioned

• Aspirin (Aspirin)

Snippet

Sponsor: FANG HE | Conditions: Preeclampsia, Perinatal Haemorrhage | Phase 3 | Status: RECRUITING